Tech firm raises £3,520 for Prostate Cancer UK at Hotel Wrexham event

Connectus Business Solutions has raised £3,520 for Prostate Cancer UK at a special fundraising event at Hotel Wrexham, featuring rugby legend Sir Ian McGeechan.

The event brought together 62 guests, including clients, partners, prospective clients, friends, family and staff, for an evening of fundraising and awareness-raising, with all proceeds going directly to the charity.

Sir Ian, 79, the former British & Irish Lions head coach, spoke candidly about his own battle with prostate cancer. The event marked a year since he announced he had been given the all-clear, making his message about early detection and diagnosis particularly poignant.

He also shared stories from his remarkable rugby career, entertaining guests with memories from his time in the sport.

Sir Ian said it was vital to do more to raise awareness of prostate cancer and the importance of early detection and diagnosis, adding that it was wonderful to be part of such a fantastic event.

Funds were raised through activities including an auction of sporting memorabilia. A highlight was an A4-sized signed drawing featuring Sir Ian, Fran Cotton and Martin Johnson CBE, commemorating the 1997 British & Irish Lions tour of South Africa. Only 300 were produced, and Sir Ian generously donated the piece to support the cause.

Roy Shelton, CEO of Connectus, said: “It was a great night, bringing together clients, partners, prospective clients, friends, family and staff in support of such an important cause. Special thanks to Sir Ian for attending, sharing his story and donating such a unique piece of rugby memorabilia.”

Guests enjoyed a British-themed menu at Hotel Wrexham, with the evening made possible by sponsors Elavade, Heimdal, Glu Digital, Magnify PR and Dropjaw Ventures.

Steven Hesketh, co-owner of Hotel Wrexham and founder of Savvy Collective, said: “It was fantastic to host such a wonderful event and help raise vital funds for Prostate Cancer UK.”

The £3,520 raised will go in full to Prostate Cancer UK, supporting its work to improve the diagnosis and treatment of prostate cancer and outcomes for men affected by the disease.